Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) FCF Margin (2016 - 2025)

Historic FCF Margin for CorMedix (CRMD) over the last 12 years, with Q3 2025 value amounting to 29.11%.

  • CorMedix's FCF Margin rose 1483400.0% to 29.11% in Q3 2025 from the same period last year, while for Sep 2025 it was 34.73%, marking a year-over-year increase of 4032600.0%. This contributed to the annual value of 116.7% for FY2024, which is 1130650900.0% down from last year.
  • According to the latest figures from Q3 2025, CorMedix's FCF Margin is 29.11%, which was up 1483400.0% from 75.42% recorded in Q2 2025.
  • In the past 5 years, CorMedix's FCF Margin registered a high of 176630.4% during Q1 2024, and its lowest value of 89069.3% during Q3 2022.
  • In the last 5 years, CorMedix's FCF Margin had a median value of 4670.76% in 2021 and averaged 266.64%.
  • In the last 5 years, CorMedix's FCF Margin surged by 2000000000bps in 2023 and then plummeted by -1765799300bps in 2025.
  • CorMedix's FCF Margin (Quarter) stood at 11522.1% in 2021, then plummeted by -84bps to 21155.46% in 2022, then skyrocketed by 661bps to 118603.6% in 2023, then tumbled by -100bps to 18.02% in 2024, then soared by 262bps to 29.11% in 2025.
  • Its FCF Margin was 29.11% in Q3 2025, compared to 75.42% in Q2 2025 and 50.47% in Q1 2025.